The roles of IL-6, IL-10, and IL-1RA in obesity and insulin resistance in African-Americans

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 12, 2011, Pages

  Charles, Bashira A ^a   Doumatey, Ayo ^a   Huang, Hanxia ^a   Zhou, Jie ^a   Chen, Guanjie ^a   Shriner, Daniel ^a   Adeyemo, Adebowale ^a   Rotimi, Charles N ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6;

ADULT; AFRICAN AMERICAN; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; BODY MASS; CONTROLLED STUDY; FAMILY STUDY; FEMALE; HIP CIRCUMFERENCE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; AFRICAN AMERICANS; FEMALE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; OBESITY;

EID: 83155165410     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1497     Document Type: Article

References (20)

1. Fève B, Bastard JP 2009 The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 5:305-311
2. Taubes G 2009 Prosperity's plague. Science 325:256-260
3. Khan LK, Sobush K, Keener D, Goodman K, Lowry A, Kakietek J, Zaro S 2009 Recommended community strategies and measurements to prevent obesity in the United States. Morbidity and mortality weekly report. Recommendations and reports. Atlanta: Centers for Disease Control and Prevention; 1-26
4. Pan L, Galuska DA, Sherry B, Hunter AS, Rutledge GE, Deitz WH, Balluz LS 2009 Differences in prevalence of obesity among black, white and Hispanic adults-United States, 2008. Morbidity and mortality weekly report. Atlanta: Centers for Disease Control and Prevention; 740-744
5. Juge-Aubry CE, Henrichot E, Meier CA 2005 Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab 19:547-566 (Pubitemid 41823815)
6. Fain JN, Gerald L 2006 Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 74:443-477
7. Mandrup-Poulsen T, Zumsteg U, Reimers J, Pociot F, Mørch L, Helqvist S, Dinarello CA, Nerup J 1993 Involvement of interleukin 1 and interleukin 1 antagonist in pancreatic β-cell destruction in insulin-dependent diabetes mellitus. Cytokine 5:185-191 (Pubitemid 23284471)
8. Herder C, Brunner EJ, Rathmann W, Strassburger K, Tabák AG, Schloot NC, Witte DR 2009 Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study. Diabetes Care 32:421-423
9. Perrier S, Darakhshan F, Hajduch E 2006 IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde? FEBS Lett 580:6289-6294 (Pubitemid 44750933)
10. Andersson CX, Gustafson B, Hammarstedt A, Hedjazifar S, Smith U 2008 Inflamed adipose tissue, insulin resistance and vascular injury. Diabetes Metab Res Rev 24:595-603
11. Roytblat L, Rachinsky M, Fisher A, Greenberg L, Shapira Y, Douvdevani A, Gelman S 2000 Raised interleukin-6 levels in obese patients. Obes Res 8:673-675
12. Blüher M, Fasshauer M, Tönjes A, Kratzsch J, Schön MR, Paschke R 2005 Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism. Exp Clin Endocrinol Diabetes 113:534-537 (Pubitemid 41585991)
13. Rotter V, Nagaev I, Smith U 2003 Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278:45777-45784 (Pubitemid 37432722)
14. Juge-Aubry CE, Somm E, Pernin A, Alizadeh N, Giusti V, Dayer JM, Meier CA 2005 Adipose tissue is a regulated source of interleukin-10. Cytokine 29:270-274 (Pubitemid 40320927)
15. Doumatey A, Lashley K, Huang H, Zhou J, Chen G, Amoah A, Agyenim-B, Kofi, Oli J, Fasanmade O, Adebomowo C, Adeyemo AA, Rotimi CN 2010 Relationships between obesity and insulin resistance in African Americans and West Africans. Obesity 18:598-603
16. Ausk KJ, Boyko EJ, Ioannou GN 2010 Insulin resistance predicts mortality in nondiabetic individuals in the U.S. Diabetes Care 33:1179-1185
17. R Development Core Team 2010 R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing
18. Wellen KE, Hotamisligil GS 2005 Inflammation stress and diabetes. J Clin Invest 115:1111-1119
19. Meier CA, Bobbioni E, Gabay C, Assimacopoulos-Jeannet F, Golay A, Dayer JM 2002 IL-1 receptor antagonist serum levels increased in human obesity: a possible link to the resistance to leptin. J Clin Endocrinol Metab 87:1184-1188 (Pubitemid 36121085)
20. Larsen CM, Faulenbach M, Vaag A, Ehses JA, Donath MY, Mandrup-Poulsen T 2009 Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 32:1663-1668